Clinical Trial

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-16
Trial Details
NCT Number NCT07548853
Lead Sponsor Taisho Pharmaceutical Co., Ltd.
Conditions Hyperphosphatemia Patients on Peritoneal Dialysis
Enrollment 30 participants
Start Date 2026-05-13
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10